PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm
news

GLP1-RAs emerge as biopharma’s most influential platform drug class, reveals GlobalData

GLP-1 receptor agonists (GLP-1RAs) have contributed significantly to the therapeutic landscape, evolving from a primarily diabetes treatment into leading weight-...
Continue Reading →
news

Biotech funding recovery favors late-stage, lower-risk assets, reveals GlobalData

The biopharmaceutical industry has seen a recovery in funding through 2026, following a prolonged downturn that limited access to capital across the sector. This...
Continue Reading →
news

Biopharma confidence reaches four-year high as dealmaking and innovation gather pace, finds GlobalData

Confidence in the biopharmaceutical industry has climbed to its highest point since 2022, signalling a sector that is regaining momentum despite persistent regul...
Continue Reading →
news

AI integration in pharmaceutical processes remains focused on high-impact functions, says GlobalData

Artificial Intelligence (AI) has shifted from an experimental technology to an industry-wide operational tool across the pharmaceutical value chain. Companies ar...
Continue Reading →
news

US drug approvals surpass 10-year average in 2025, reveals GlobalData

The US FDA approved 131 drugs last year through its New Drug Application (NDA), Biologics License Application (BLA), and biosimilar pathways, leading to a steady...
Continue Reading →
news

Penumbra’s THUNDERBOLT approval tests peripheral momentum in high-stakes neurovascular market, says GlobalData

Penumbra has recently received FDA approval and CE mark for its THUNDERBOLT system, the first computer-assisted vacuum therapy (CAVT) for stroke. Having recently...
Continue Reading →
news

Camgenium Launches Foundation Platform: Pre-certified Infrastructure for Connected Medical Device Development

Foundation Platform provides pre-certified firmware, cloud infrastructure and compliance reporting Enables connected medical device teams to focus on clinica...
Continue Reading →
news

Neurizon Executes Long-Term Supply Agreement with Elanco Strengthening Commercialisation Readiness

Highlights: Neurizon executes long-term supply agreement with Elanco Animal Health (Elanco), with an initial five-year term The agreement provides long-te...
Continue Reading →
news

Single Use Support Launches Next-Generation Controlled-Rate Blast Freezer

Single Use Support introduces the advanced RoSS.BLST, a blast freezing and thawing platform designed to deliver maximum process consistency and product quality ...
Continue Reading →
news

Cresset releases Flare V12 to cut synthesis and testing cycles with faster, more flexible FEP

Cresset has released Flare V12, a new version of its computer-aided drug design (CADD) solution for the discovery, design and optimisation of small molecules. Fl...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC